Search Results - "Santos‐Laso, Álvaro"
-
1
miR-21-5p promotes NASH-related hepatocarcinogenesis
Published in Liver international (01-10-2023)“…The mechanisms governing the progression of non-alcoholic fatty liver disease (NAFLD) towards steatohepatitis (NASH) and hepatocellular carcinoma (HCC) remain…”
Get full text
Journal Article -
2
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
Published in Hepatology (Baltimore, Md.) (01-10-2017)“…Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis. Several conditions, such as primary sclerosing cholangitis…”
Get full text
Journal Article -
3
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
Published in Hepatology (Baltimore, Md.) (01-08-2019)“…Early and differential diagnosis of intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC) by noninvasive methods represents a current…”
Get full text
Journal Article -
4
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
Published in Hepatology (Baltimore, Md.) (01-06-2021)“…Background and Aims Intrahepatic cholangiocarcinoma (iCCA) with liver metastases is perceived to have a poor prognosis, but the American Joint Committee on…”
Get full text
Journal Article -
5
MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation
Published in Hepatology (Baltimore, Md.) (01-04-2018)“…Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease associated with autoimmune phenomena targeting intrahepatic bile duct cells…”
Get full text
Journal Article -
6
Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease
Published in International journal of molecular sciences (24-03-2023)“…Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent cause of chronic liver disease (CLD). Currently, the only therapeutic recommendation…”
Get full text
Journal Article -
7
Dual Targeting of G9a and DNA Methyltransferase‐1 for the Treatment of Experimental Cholangiocarcinoma
Published in Hepatology (Baltimore, Md.) (01-06-2021)“…Background and Aims Cholangiocarcinoma (CCA) is a devastating disease often detected at advanced stages when surgery cannot be performed. Conventional and…”
Get full text
Journal Article -
8
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets
Published in Liver international (01-07-2020)“…Background & Aims Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive development of multiple biliary cysts. Recently, novel…”
Get full text
Journal Article -
9
Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage
Published in Gut (01-03-2019)“…Liver injury impacts hepatic inflammation in part via Toll-like receptor (TLR) signalling. Triggering receptor expressed on myeloid cells 2 (TREM-2) modulates…”
Get more information
Journal Article -
10
Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?
Published in Journal of hepatology (01-12-2018)“…Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease associated with autoimmune-related destruction of small to medium size intrahepatic…”
Get full text
Journal Article -
11
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
Published in Gut (01-12-2021)“…Receptor-interacting protein kinase 3 (RIPK3) is a key player in necroptosis execution and an emerging metabolic regulator, whose contribution to non-alcoholic…”
Get more information
Journal Article -
12
Dual Targeting of Histone Methyltransferase G9a and DNA‐Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma
Published in Hepatology (Baltimore, Md.) (01-02-2019)“…Epigenetic modifications such as DNA and histone methylation functionally cooperate in fostering tumor growth, including that of hepatocellular carcinoma…”
Get full text
Journal Article -
13
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma
Published in Journal of hepatology (01-07-2017)“…Graphical abstract…”
Get full text
Journal Article -
14
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
Published in International journal of molecular sciences (24-04-2023)“…Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, and its incidence has been increasing in recent years…”
Get full text
Journal Article -
15
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key
Published in International journal of molecular sciences (27-06-2023)“…Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of disorders ranging from simple steatosis to non-alcoholic steatohepatitis (NASH). Hepatic…”
Get full text
Journal Article -
16
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease
Published in Hepatology (Baltimore, Md.) (01-01-2021)“…Background and Aims Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive development of symptomatic biliary cysts. Current…”
Get full text
Journal Article -
17
Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home
Published in Scientific reports (10-05-2021)“…The simplicity and low cost of rapid point-of-care tests greatly facilitate large-scale population testing, which can contribute to controlling the spread of…”
Get full text
Journal Article -
18
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease
Published in Journal of hepatology (01-10-2015)“…Background & Aims Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive biliary cystogenesis. Current therapies show short-term…”
Get full text
Journal Article -
19
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis
Published in Cells (Basel, Switzerland) (14-03-2020)“…Cholangiocarcinoma (CCA) comprises a group of heterogeneous biliary cancers with dismal prognosis. The etiologies of most CCAs are unknown, but primary…”
Get full text
Journal Article -
20
Adiponectin, Leptin, and IGF-1 are useful diagnostic and stratification biomarkers of NAFLD
Published in Frontiers in medicine (23-06-2021)“…Copyright © 2021 Marques, Afonso, Bierig, Duarte-Ramos, Santos-Laso, Jimenez-Agüero, Eizaguirre, Bujanda, Pareja, Luís, Costa, Machado, Alonso, Arretxe,…”
Get full text
Journal Article